Home / Hepatitis B, Purified Antigen / Switzerland
CH ATC J07BC01 · updated 2 Nov 2026
Hepatitis B, Purified Antigen shortage in Switzerland
Is there a Hepatitis B, Purified Antigen shortage in Switzerland?
Yes. As of 2 Nov 2026, 1 Hepatitis B, Purified Antigen product is reported short in Switzerland, the first since 1 May 2026. No return date has been given. Main reason: not stated.
Also short in Italy, Belgium. All countries.
Affected products in Switzerland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | HBVAXPRO Inj Susp 40 µg 1 Stk | MSD Merck Sharp & Dohme AG | 1 May 2026 | not given | Not stated |
Source
FONES (Federal Office for National Economic Supply), reporting office for vital medicines. Official list. Vital human medicines only (the federal list of reportable active substances); one row per pack (GTIN).